搜索临床试验以:Palbociclib Letrozole
总计938个结果
-
Consorzio Oncotech招聘中
-
Canadian Cancer Trials GroupPfizer完全的
-
Genor Biopharma Co., Ltd.招聘中
-
National Taiwan University Hospital未知
-
The Affiliated Hospital of Qingdao University尚未招聘
-
Swiss GO Trial GroupHoffmann-La Roche; Novartis Pharmaceuticals; AGO Study Group; Anticancer Fund, Belgium; Arbeitsgemeinschaft... 和其他合作者招聘中输卵管肿瘤 | 腹膜肿瘤 | 卵巢肿瘤上皮 | 高级别浆液性卵巢癌 (HGSOC) | 低级别浆液性卵巢癌 (LGSOC) | 卵巢子宫内膜样癌奥地利, 瑞士, 德国
-
Assistance Publique - Hôpitaux de Paris未知乳腺癌 | 转移 | HR+/HER2 阴性乳腺癌
-
Peking University Cancer Hospital & InstituteKiang Wu Hospital未知
-
Zagazig University完全的
-
Samsung Medical CenterKorean Cancer Study Group招聘中
-
Grupo Espanol de Investigacion en Sarcomas招聘中
-
Rush University Medical Center完全的晚期乳腺癌 | 转移性乳腺癌 | 雌激素受体阳性乳腺癌 | 人类表皮生长因子 2 阴性乳腺癌
-
American Society of Clinical OncologyPatient-Centered Outcomes Research Institute尚未招聘转移性乳腺癌
-
Jonsson Comprehensive Cancer Center完全的
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; Novartis Pharmaceuticals; University of California, San Francisco; Abbott 和其他合作者完全的
-
UNICANCER完全的
-
EQRx International, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups (ENGOT)撤销
-
University of California, San FranciscoEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)招聘中
-
Heilongjiang University of Chinese MedicineMinistry of Science and Technology of the People´s Republic of China未知
-
ETOP IBCSG Partners FoundationPfizer; Hoffmann-La Roche完全的
-
Jonsson Comprehensive Cancer CenterBayer; Translational Research in Oncology-U.S. Inc. (TRIO-US)终止I期乳腺癌 | IV 期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | 浸润性乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阳性 | HER2/Neu 阴性 | 孕激素受体阳性 | III期乳腺癌 | 绝经后 | 多灶性乳腺癌美国
-
Borstkanker Onderzoek GroepNovartis; Philips Healthcare主动,不招人
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); European Organisation for Research and Treatment of Cancer... 和其他合作者完全的